Showing Form 4 filings for ROIV
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Roivant Sciences Ltd.
Price
$38.75
Shares
1,381,762
Ownership
19,304,554
Value/Share
Manchester Keith S
Dir
Unknown
Industry
Gold Daniel Allen
Qvt Financial LP
Director by Deputization
$36.31
200,000
999,154
Venker Eric
Pres, Immunovant CEO
$36.59
1,199,154
$35.11
1,399,154